HAAO encodes 3-hydroxyanthranilate 3,4-dioxygenase (3-HAO; EC 1.13.11.6), a cytosolic non-heme ferrous-iron (Fe2+)-dependent dioxygenase acting in the kynurenine pathway of L-tryptophan catabolism. It catalyzes the oxidative ring opening of 3-hydroxyanthranilate, incorporating both atoms of molecular oxygen to yield 2-amino-3-carboxymuconate-6-semialdehyde (ACMS). ACMS cyclizes spontaneously to quinolinate, the universal precursor for de novo NAD+ biosynthesis from tryptophan (via quinolinate phosphoribosyltransferase), unless it is diverted by ACMSD toward picolinate and glutaryl-CoA. HAAO thus sits immediately upstream of quinolinate and de novo NAD+ synthesis. The 286-residue protein is a monomer with a bicupin (RmlC-like cupin/jelly-roll) fold; the active-site catalytic iron is coordinated by conserved His and Glu residues, and Zn2+ is an in vitro inhibitor. The enzyme is highly expressed in liver. Biallelic loss-of-function variants in HAAO cause a congenital NAD-deficiency malformation syndrome (vertebral, cardiac, renal, and limb defects), which in mouse models is preventable by niacin supplementation during gestation. Because quinolinate is a potent excitotoxin, 3-HAO activity has also been studied in neurological disease.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0019805 quinolinate biosynthetic process | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetic (IBA) propagation of the quinolinate biosynthetic process. This is a core biological role of HAAO: its product ACMS cyclizes spontaneously to quinolinate. Consistent with experimental annotations (PMID:7514594, PMID:12007609, PMID:28792876) and UniProt PATHWAY "quinolinate from L-kynurenine: step 3/3". |
| GO:0034354 'de novo' NAD+ biosynthetic process from L-tryptophan | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetic (IBA) propagation of de novo NAD+ biosynthesis from L-tryptophan. This is a core pathway-level role for HAAO, which generates quinolinate, the precursor of de novo NAD+. Directly supported by PMID:28792876 (HAAO loss-of-function causes systemic NAD deficiency). |
| GO:0005737 cytoplasm | IBA GO_REF:0000033 | MODIFY | Summary: Phylogenetic (IBA) cytoplasm annotation. Correct but less specific than the experimentally supported cytosol (GO:0005829). Retained as a non-core, less-informative parent of the cytosol location. Proposed replacements: cytosol |
| GO:0000334 3-hydroxyanthranilate 3,4-dioxygenase activity | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetic (IBA) propagation of the defining catalytic molecular function. This is the core function of HAAO and is independently confirmed by multiple experimental (IDA) annotations (PMID:7514594, PMID:12007609, PMID:28792876). |
| GO:0000334 3-hydroxyanthranilate 3,4-dioxygenase activity | IEA GO_REF:0000120 | ACCEPT | Summary: Electronic (ARBA/UniRule/EC-based) assignment of the defining catalytic activity. Correct; redundant with the experimental IDA annotations. |
| GO:0005506 iron ion binding | IEA GO_REF:0000002 | MODIFY | Summary: InterPro2GO electronic assignment of iron ion binding. Correct in essence but less specific than the experimentally demonstrated ferrous (Fe2+) iron binding (GO:0008198, IDA from PMID:12007609 and PMID:28375145). The enzyme strictly requires Fe(II). Proposed replacements: ferrous iron binding |
| GO:0005737 cytoplasm | IEA GO_REF:0000120 | MODIFY | Summary: Electronic cytoplasm location. Correct but less specific than the experimentally supported cytosol (GO:0005829, IDA PMID:7514594). Proposed replacements: cytosol |
| GO:0005829 cytosol | IEA GO_REF:0000044 | ACCEPT | Summary: Electronic (UniProt subcellular location) cytosol annotation. Correct and consistent with the experimental IDA cytosol annotation (PMID:7514594). |
| GO:0006569 L-tryptophan catabolic process | IEA GO_REF:0000104 | KEEP AS NON CORE | Summary: Electronic (UniRule) assignment placing HAAO in tryptophan catabolism. Biologically correct: 3-HAO is a kynurenine-pathway enzyme of tryptophan degradation. Retained as an accurate higher-level BP; the more specific quinolinate/NAD+ biosynthesis terms are the core annotations. |
| GO:0008198 ferrous iron binding | IEA GO_REF:0000104 | ACCEPT | Summary: Electronic (UniRule) ferrous iron binding. Correct and matches the experimental IDA annotations (PMID:12007609, PMID:28375145). Fe(II) is the strictly required catalytic cofactor. |
| GO:0019805 quinolinate biosynthetic process | IEA GO_REF:0000104 | ACCEPT | Summary: Electronic (UniRule) quinolinate biosynthesis. Core BP role, redundant with experimental IDA/NAS annotations. |
| GO:0034354 'de novo' NAD+ biosynthetic process from L-tryptophan | IEA GO_REF:0000104 | ACCEPT | Summary: Electronic (UniRule) de novo NAD+ biosynthesis from tryptophan. Core pathway role, supported by the disease genetics (PMID:28792876). |
| GO:0046872 metal ion binding | IEA GO_REF:0000002 | MARK AS OVER ANNOTATED | Summary: InterPro2GO generic metal ion binding. True but uninformative; the specific and experimentally supported ferrous iron binding (GO:0008198) captures the actual cofactor. Marked as over-annotated (over-general). |
| GO:0005515 protein binding | IPI PMID:16189514 Towards a proteome-scale map of the human protein-protein in... | MARK AS OVER ANNOTATED | Summary: Bare "protein binding" from a large-scale Y2H interactome map (Rual et al. 2005, CCSB-HI1). Uninformative for molecular function and not tied to any characterized complex or biological role for this cytosolic enzyme (UniProt lists only screen-derived GAD1/POT1 interactions). Not removed per policy; flagged as over-annotated. |
| GO:0005515 protein binding | IPI PMID:21044950 Genome-wide YFP fluorescence complementation screen identifi... | MARK AS OVER ANNOTATED | Summary: Bare "protein binding" from a genome-wide split-Venus BiFC telomere- interactome screen (Lee et al. 2011); the POT1 (Q9NUX5) pairing is a high-throughput screen hit with no established functional relationship to a cytosolic kynurenine-pathway enzyme. Uninformative for MF; not removed per policy; flagged as over-annotated. |
| GO:0005515 protein binding | IPI PMID:25416956 A proteome-scale map of the human interactome network. | MARK AS OVER ANNOTATED | Summary: Bare "protein binding" from the HI-II-14 systematic binary interactome map (Rolland et al. 2014). Uninformative for MF; not removed per policy; flagged as over-annotated. |
| GO:0005515 protein binding | IPI PMID:31515488 Extensive disruption of protein interactions by genetic vari... | MARK AS OVER ANNOTATED | Summary: Bare "protein binding" from an ExAC-variant Y2H interaction screen (Fragoza et al. 2019). Uninformative for MF; not removed per policy; flagged as over-annotated. |
| GO:0005515 protein binding | IPI PMID:32296183 A reference map of the human binary protein interactome. | MARK AS OVER ANNOTATED | Summary: Bare "protein binding" from the HuRI reference binary interactome (Luck et al. 2020). Uninformative for MF; not removed per policy; flagged as over-annotated. |
| GO:0009435 NAD+ biosynthetic process | IEA GO_REF:0000041 | KEEP AS NON CORE | Summary: Electronic (UniPathway) NAD+ biosynthetic process. Correct but less specific than the de novo NAD+ biosynthesis from L-tryptophan term (GO:0034354). Retained as a non-core, more-general parent. |
| GO:0000334 3-hydroxyanthranilate 3,4-dioxygenase activity | IDA PMID:28792876 NAD Deficiency, Congenital Malformations, and Niacin Supplem... | ACCEPT | Summary: Direct assay (IDA) of the defining catalytic activity: recombinant HAAO and its VCRL1 truncation variants were tested for enzyme activity, with "greatly reduced activity in vitro" for the mutants. Core molecular function. |
| GO:0008198 ferrous iron binding | IDA PMID:28375145 Crystal structures of human 3-hydroxyanthranilate 3,4-dioxyg... | ACCEPT | Summary: Direct assay (IDA) of ferrous iron binding, from crystal structures with native iron bound in the active site; "non-heme iron-containing, ring-cleaving extradiol dioxygenase". Core cofactor-binding function. |
| GO:0009435 NAD+ biosynthetic process | IMP PMID:28792876 NAD Deficiency, Congenital Malformations, and Niacin Supplem... | KEEP AS NON CORE | Summary: IMP from human/mouse loss-of-function genetics: biallelic HAAO loss-of-function causes systemic NAD deficiency ("The patients had reduced levels of circulating NAD"; Haao-null mice reproduce the phenotype). Correct but less specific than the de novo NAD+ from L-tryptophan term (GO:0034354). Retained as non-core relative to the more specific term. |
| GO:0019805 quinolinate biosynthetic process | IDA PMID:28792876 NAD Deficiency, Congenital Malformations, and Niacin Supplem... | ACCEPT | Summary: IDA supporting quinolinate biosynthesis (enzyme assay of HAAO forming the quinolinate precursor). Core biological process for HAAO. |
| GO:0005829 cytosol | TAS Reactome:R-HSA-71218 | ACCEPT | Summary: Reactome TAS cytosol location for the 3-hydroxyanthranilate + O2 reaction ("Cytosolic 3-hydroxyanthranilate oxygenase ..."). Consistent with the experimental IDA cytosol annotation. Core localization. |
| GO:0000334 3-hydroxyanthranilate 3,4-dioxygenase activity | IDA PMID:12007609 Cloning of human 3-hydroxyanthranilic acid dioxygenase in Es... | ACCEPT | Summary: Direct assay (IDA) of the catalytic activity of purified recombinant human 3-HAO expressed in E. coli, converting 3-hydroxyanthranilic acid to quinolinic acid. Core molecular function. |
| GO:0000334 3-hydroxyanthranilate 3,4-dioxygenase activity | IDA PMID:7514594 Molecular cloning and functional expression of human 3-hydro... | ACCEPT | Summary: Direct assay (IDA) from the original cloning/functional expression of human 3-HAO; recombinant enzyme catalyzes quinolinate synthesis with Km(3-HANA) ~2 microM. Core molecular function. |
| GO:0005829 cytosol | IDA PMID:7514594 Molecular cloning and functional expression of human 3-hydro... | ACCEPT | Summary: IDA cytosol localization from the cloning/expression study; matches UniProt "Cytoplasm, cytosol" and Reactome. Core localization. |
| GO:0008198 ferrous iron binding | IDA PMID:12007609 Cloning of human 3-hydroxyanthranilic acid dioxygenase in Es... | ACCEPT | Summary: IDA ferrous iron binding: enzymatic activity "can occur only in the presence of Fe(II)"; other metals do not support catalysis. Core cofactor-binding function. |
| GO:0009055 electron transfer activity | NAS PMID:7514594 Molecular cloning and functional expression of human 3-hydro... | MARK AS OVER ANNOTATED | Summary: NAS "electron transfer activity" is mechanistically incorrect for HAAO: it is a non-heme Fe(II) extradiol dioxygenase that incorporates both atoms of O2 into the substrate during ring cleavage (PMID:28375145), not an electron carrier. This is an author-statement over-annotation superseded by the structural/mechanistic characterization. Marked as over-annotated (retained per NAS/non-experimental over-annotation policy). |
| GO:0010043 response to zinc ion | IDA PMID:12007609 Cloning of human 3-hydroxyanthranilic acid dioxygenase in Es... | MARK AS OVER ANNOTATED | Summary: IDA "response to zinc ion" derives from the in vitro observation that Zn2+ inhibits 3-HAO catalysis ("Zn2+, could be of physiological relevance" as an inhibitor). Inhibitor sensitivity of a purified enzyme is not evidence that HAAO participates in a cellular response-to-zinc process; this is an over-interpretation of an inhibition assay. Kept (experimental IDA) but flagged as over-annotated. |
| GO:0019805 quinolinate biosynthetic process | NAS PMID:12007609 Cloning of human 3-hydroxyanthranilic acid dioxygenase in Es... | ACCEPT | Summary: NAS quinolinate biosynthesis; correct core BP, redundant with the experimental IDA annotations for the same term. |
| GO:0019805 quinolinate biosynthetic process | NAS PMID:7514594 Molecular cloning and functional expression of human 3-hydro... | ACCEPT | Summary: NAS quinolinate biosynthesis from the original cloning paper; correct core BP, redundant with the experimental IDA annotations. |
| GO:0046686 response to cadmium ion | IDA PMID:12007609 Cloning of human 3-hydroxyanthranilic acid dioxygenase in Es... | MARK AS OVER ANNOTATED | Summary: IDA "response to cadmium ion" traces to in vitro metal-inhibition testing of purified 3-HAO. As with the zinc annotation, in vitro metal inhibition is not evidence of a cellular response-to-cadmium process. Kept (experimental IDA) but flagged as over-annotated. |
| GO:0070050 neuron cellular homeostasis | IMP PMID:2967497 3-Hydroxyanthranilate oxygenase activity is increased in the... | KEEP AS NON CORE | Summary: Based on the observation that 3-hydroxyanthranilate oxygenase activity is increased in Huntington disease striatum (PMID:2967497), linking excess quinolinate to excitotoxic neuronal loss. This is a disease-correlation finding about pathway activity, not a demonstration that HAAO maintains neuronal homeostasis; the term is peripheral to the core enzymatic role. Retained as a non-core, disease-context process annotation. |
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)